<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1296" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1296/" /><meta name="ncbi_pagename" content="Niemann-Pick Disease Type C - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Niemann-Pick Disease Type C - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Niemann-Pick Disease Type C" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/08/29" /><meta name="citation_author" content="Marc Patterson" /><meta name="citation_pmid" content="20301473" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1296/" /><meta name="citation_keywords" content="Juvenile Niemann-Pick Disease" /><meta name="citation_keywords" content="Juvenile Niemann-Pick Disease" /><meta name="citation_keywords" content="NPC intracellular cholesterol transporter 1" /><meta name="citation_keywords" content="NPC intracellular cholesterol transporter 2" /><meta name="citation_keywords" content="NPC1" /><meta name="citation_keywords" content="NPC2" /><meta name="citation_keywords" content="Niemann-Pick Disease Type C" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Niemann-Pick Disease Type C" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Marc Patterson" /><meta name="DC.Date" content="2019/08/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1296/" /><meta name="description" content="Niemann-Pick disease type C (NPC) is a lipid storage disease that can present in infants, children, or adults. Neonates can present with ascites and severe liver disease from infiltration of the liver and/or respiratory failure from infiltration of the lungs. Other infants, without liver or pulmonary disease, have hypotonia and developmental delay. The classic presentation occurs in mid-to-late childhood with the insidious onset of ataxia, vertical supranuclear gaze palsy (VSGP), and dementia. Dystonia and seizures are common. Dysarthria and dysphagia eventually become disabling, making oral feeding impossible; death usually occurs in the late second or third decade from aspiration pneumonia. Adults are more likely to present with dementia or psychiatric symptoms." /><meta name="og:title" content="Niemann-Pick Disease Type C" /><meta name="og:type" content="book" /><meta name="og:description" content="Niemann-Pick disease type C (NPC) is a lipid storage disease that can present in infants, children, or adults. Neonates can present with ascites and severe liver disease from infiltration of the liver and/or respiratory failure from infiltration of the lungs. Other infants, without liver or pulmonary disease, have hypotonia and developmental delay. The classic presentation occurs in mid-to-late childhood with the insidious onset of ataxia, vertical supranuclear gaze palsy (VSGP), and dementia. Dystonia and seizures are common. Dysarthria and dysphagia eventually become disabling, making oral feeding impossible; death usually occurs in the late second or third decade from aspiration pneumonia. Adults are more likely to present with dementia or psychiatric symptoms." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1296/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/npc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1296/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE893577DFC8A281000000000556028C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1296_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1296_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/nbs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/nijmegen/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1296_"><span class="title" itemprop="name">Niemann-Pick Disease Type C</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Juvenile Niemann-Pick Disease</div><p class="contrib-group"><span itemprop="author">Marc Patterson</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1296_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1296_ai__"><div class="contrib half_rhythm"><span itemprop="author">Marc Patterson</span>, MD<div class="affiliation small">Mayo Clinic<br />Rochester, Minnesota<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.oyam@cram.nosrettap" class="oemail">ude.oyam@cram.nosrettap</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 26, 2000</span>; Last Revision: <span itemprop="dateModified">August 29, 2019</span>.</p><p><em>Estimated reading time: 27 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="npc.Summary" itemprop="description"><h2 id="_npc_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Niemann-Pick disease type C (NPC) is a lipid storage disease that can present in infants, children, or adults. Neonates can present with ascites and severe liver disease from infiltration of the liver and/or respiratory failure from infiltration of the lungs. Other infants, without liver or pulmonary disease, have hypotonia and developmental delay. The classic presentation occurs in mid-to-late childhood with the insidious onset of ataxia, vertical supranuclear gaze palsy (VSGP), and dementia. Dystonia and seizures are common. Dysarthria and dysphagia eventually become disabling, making oral feeding impossible; death usually occurs in the late second or third decade from aspiration pneumonia. Adults are more likely to present with dementia or psychiatric symptoms.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of NPC is confirmed by biochemical testing that demonstrates impaired cholesterol esterification and positive filipin staining in cultured fibroblasts. Biochemical testing for <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status is unreliable. Most individuals with NPC have NPC1, caused by pathogenic variants in <i>NPC1</i>; fewer than 20 individuals have been diagnosed with NPC2, caused by pathogenic variants in <i>NPC2</i>. Molecular genetic testing of <i>NPC1</i> and <i>NPC2</i> detects pathogenic variants in approximately 94% of individuals with NPC.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Symptomatic therapy for seizures, dystonia, and cataplexy; a nocturnal sedative to help disordered sleep; physical therapy to maintain mobility as long as possible.</p><p><i>Prevention of secondary complications:</i> Chest physical therapy with aggressive bronchodilation and antibiotic therapy of intercurrent infection; regular bowel program for mobility-impaired individuals to prevent severe constipation and resulting increased seizure frequency and/or increased spasticity.</p><p><i>Surveillance:</i> Swallowing is monitored to allow placement of a gastrostomy tube when aspiration or nutritional compromise is imminent.</p><p><i>Agents/circumstances to avoid:</i> Drugs that cause excessive salivation or that may exacerbate seizures by interacting with antiepileptic drugs; alcohol and other drugs that may exacerbate ataxia.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>NPC is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., age of onset and severity of symptoms) usually runs true in families. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants have been identified in the family.</p></div></div><div id="npc.Diagnosis"><h2 id="_npc_Diagnosis_">Diagnosis</h2><div id="npc.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The diagnosis of Niemann-Pick disease type C (NPC) should be considered in individuals presenting with the following [<a class="bk_pop" href="#npc.REF.vanier.1997.68">Vanier 1997</a>]:</p><ul><li class="half_rhythm"><div>Fetal ascites or neonatal liver disease, particularly when the latter is accompanied by prolonged jaundice and pulmonary infiltrates</div></li><li class="half_rhythm"><div>Infantile hypotonia without evidence of progression for months to years, followed by features outlined in <a class="bk_pop" href="#npc.REF.brady.1989.75">Brady et al [1989]</a>; see VSGP (following)</div></li><li class="half_rhythm"><div>Vertical supranuclear gaze palsy (VSGP), followed by progressive ataxia, dysarthria, dystonia, and, in some cases, seizures and gelastic cataplexy, beginning in middle childhood, and progressing slowly over many years. Rarely, such presentations may begin later in childhood or in adulthood.</div></li><li class="half_rhythm"><div>Psychiatric presentations, mimicking depression or schizophrenia, with few or subtle neurologic signs, beginning in adolescence or adulthood</div></li><li class="half_rhythm"><div>Enlargement of the liver or spleen, particularly in early childhood</div></li></ul><p>A quantitative scoring system that weights the manifestations of NPC has been developed to assist clinicians in selecting appropriate individuals for further laboratory investigation [<a class="bk_pop" href="#npc.REF.wijburg.2012.1560">Wijburg et al 2012</a>].</p></div><div id="npc.Testing"><h3>Testing</h3><p><b>Biochemical.</b> Until recently, definitive diagnosis of NPC required demonstration of abnormal intracellular cholesterol homeostasis in cultured fibroblasts [<a class="bk_pop" href="#npc.REF.pentchev.1985.8247">Pentchev et al 1985</a>]. These cells show reduced ability to esterify cholesterol after loading with exogenously derived LDL-cholesterol. Filipin staining demonstrates an intense punctate pattern of fluorescence concentrated around the nucleus, consistent with the accumulation of unesterified cholesterol:</p><ul><li class="half_rhythm"><div><b>Classic.</b> Most individuals have zero or very low esterification levels with a classic staining pattern.</div></li><li class="half_rhythm"><div><b>Variant.</b> About 15% of individuals have intermediate or "variant" levels of cholesterol esterification and a less distinctive staining pattern. More precise characterization of the biochemical defect in this group can be achieved by the use of BODIPY-lactosylceramide to identify lipid trafficking abnormalities [<a class="bk_pop" href="#npc.REF.sun.2001.1361">Sun et al 2001</a>].</div></li></ul><p>Assay of oxysterols has largely replaced skin biopsy, and is now regarded as both a robust screening test and a first-line diagnostic test for Niemann-Pick disease, type C [<a class="bk_pop" href="#npc.REF.porter.2010.56ra81">Porter et al 2010</a>, <a class="bk_pop" href="#npc.REF.jiang.2011.1435">Jiang et al 2011</a>, <a class="bk_pop" href="#npc.REF.geberhiwot.2018.50">Geberhiwot et al 2018</a>].</p><p><b>Histology.</b> Other tests, including tissue biopsies and tissue lipid analysis, which were essential for diagnosis before recognition of the biochemical defect in NPC, are now rarely needed. These tests include examination of bone marrow, spleen, and liver, which contain foamy cells (lipid-laden macrophages); sea-blue histiocytes may be seen in the marrow in advanced cases. Electron microscopy of skin, rectal neurons, liver, or brain may show polymorphous cytoplasmic bodies [<a class="bk_pop" href="#npc.REF.boustany.1990.177">Boustany et al 1990</a>].</p><div id="npc.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Genes.</b> Pathogenic variants in two genes are known to cause Niemann-Pick disease type C (NPC): <i>NPC1</i> and <i>NPC2</i>.</p><p><b>Evidence for further <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity.</b> No direct evidence exists for other loci; however, in some individuals with the typical clinical and biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, pathogenic variants have not been found in <i>NPC1</i> or <i>NPC2</i>.</p><div id="npc.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Niemann-Pick Disease Type C</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1296/table/npc.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__npc.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of NPC Attributed to Mutation of Gene&#x000a0;<sup>2</sup></th><th id="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>3</sup></th><th id="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Gene and Method&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>NPC1</i></td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">90%&#x000a0;<sup>5</sup></td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">80%-90%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>8</sup></td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial- and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vary panels differ by laboratory</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vary&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>NPC2</i></td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">4%</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Close to 100%</td></tr><tr><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>8</sup></td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial- and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown; none reported&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant panels differ by laboratory</td><td headers="hd_h_npc.T.molecular_genetic_testing_used_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vary</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="npc.TF.1.1"><p class="no_margin">See <a href="/books/NBK1296/#npc.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="npc.TF.1.2"><p class="no_margin">Percent of individuals with NPC who have at least one identifiable <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#npc.REF.greer.1999.1252">Greer et al 1999</a>, <a class="bk_pop" href="#npc.REF.yamamoto.1999.10">Yamamoto et al 1999</a>, <a class="bk_pop" href="#npc.REF.park.2003.313">Park et al 2003</a>] using a variant scanning testing method</p></div></dd><dt>3. </dt><dd><div id="npc.TF.1.3"><p class="no_margin">See <a href="#npc.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>4. </dt><dd><div id="npc.TF.1.4"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>5. </dt><dd><div id="npc.TF.1.5"><p class="no_margin">Detection rates using <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> may be comparable to those found using scanning for pathogenic variants, which has identified <i>NPC1</i> variants in 90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#npc.REF.park.2003.313">Park et al 2003</a>, <a class="bk_pop" href="#npc.REF.patterson.2012.330">Patterson et al 2012</a>].</p></div></dd><dt>6. </dt><dd><div id="npc.TF.1.6"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>7. </dt><dd><div id="npc.TF.1.7"><p class="no_margin">Most individuals with NPC1 are compound heterozygotes with pathogenic variants unique to their family; to date, pathogenic variants in one or both <i>NPC1</i> alleles cannot be identified in a substantial number of cases [<a class="bk_pop" href="#npc.REF.greer.1999.1252">Greer et al 1999</a>, <a class="bk_pop" href="#npc.REF.yamamoto.1999.10">Yamamoto et al 1999</a>, <a class="bk_pop" href="#npc.REF.park.2003.313">Park et al 2003</a>].</p></div></dd><dt>8. </dt><dd><div id="npc.TF.1.8"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>9. </dt><dd><div id="npc.TF.1.9"><p class="no_margin">Few have been reported; the frequency of such variants may be rare.</p></div></dd><dt>10. </dt><dd><div id="npc.TF.1.10"><p class="no_margin">Of note, individuals with <i>NPC1</i> from Nova Scotia (previously said to have Niemann-Pick type D) almost uniformly have the <a class="figpopup" href="/books/NBK1296/table/npc.T.npc1_variants_discussed_in_this_ge/?report=objectonly" target="object" rid-figpopup="fignpcTnpc1variantsdiscussedinthisge" rid-ob="figobnpcTnpc1variantsdiscussedinthisge">p.Gly992Trp</a> variant [<a class="bk_pop" href="#npc.REF.greer.1998.52">Greer et al 1998</a>].</p></div></dd><dt>11. </dt><dd><div id="npc.TF.1.11"><p class="no_margin">No large insertions or deletions have been reported in <i>NPC2</i>. Based on the high <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the <i>NPC2</i> sequencing test, a screening test for large deletions/duplications may have a very low yield.</p></div></dd></dl></div></div></div></div></div><div id="npc.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Biochemical testing demonstrating elevated levels of oxysterols is now the mainstay of diagnosis and may be supported in selected cases by demonstration of abnormal intracellular cholesterol homeostasis in cultured fibroblasts or by ultrastructural changes on skin or rectal biopsy.</div></li><li class="half_rhythm"><div>Molecular genetic testing is necessary to confirm the diagnosis in all individuals with suspected NPC.</div></li></ul><p><b>Carrier testing for at-risk relatives</b> requires prior identification of the pathogenic variants in the family.</p><p>Note: Carriers are heterozygotes for this <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder and are not at risk of developing the disorder.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p></div></div><div id="npc.Clinical_Characteristics"><h2 id="_npc_Clinical_Characteristics_">Clinical Characteristics</h2><div id="npc.Clinical_Description"><h3>Clinical Description</h3><p>Niemann-Pick disease type C (NPC) may present at any age.</p><p><b>Neonatal and infantile presentations.</b> The presentation of NPC in early life is nonspecific and may go unrecognized by inexperienced clinicians. On occasion, ultrasound examination in late pregnancy has detected fetal ascites; infants thus identified typically have severe neonatal liver disease with jaundice and persistent ascites.</p><p>Infiltration of the lungs with foam cells may accompany neonatal liver disease or occur as a primary presenting feature (pulmonary failure secondary to impaired diffusion).</p><p>Many infants succumb at this stage. Of those who survive, some are hypotonic and delayed in psychomotor development, whereas others may have complete resolution of symptoms, only to present with neurologic disease many years later. Liver and spleen are enlarged in children with symptomatic hepatic disease; however, children who survive often "grow into their organs," so that organomegaly may not be detectable later in childhood. Indeed, many individuals with NPC never have organomegaly. The absence of organomegaly never eliminates the diagnosis of NPC.</p><p>Another subgroup of children has minimal or absent hepatic or pulmonary dysfunction and presents primarily with hypotonia and delayed development. Children in this group usually do not have vertical supranuclear gaze palsy (VSGP) at the onset but acquire this sign after a variable period, when other evidence of progressive encephalopathy supervenes.</p><p><b>Childhood presentations.</b> The classic presentation of NPC is in middle-to-late childhood, with clumsiness and gait disturbance that eventually become frank ataxia. Many observant parents are aware of impaired vertical gaze, which is an early manifestation. VSGP first manifests as increased latency in initiation of vertical saccades, after which saccadic velocity gradually slows and is eventually lost. In late stages of the illness, horizontal saccades are also impaired. The physical manifestations are accompanied by insidiously progressive cognitive impairment, often mistaken at first for simple learning disability. Some children are thought to have primary behavioral disturbances, reflecting unrecognized dyspraxia in some instances. As the disease progresses, it becomes clear that the child is mentally deteriorating.</p><p>In addition to the manifestations outlined above, many children develop dystonia, typically beginning as action dystonia in one limb and gradually spreading to involve all of the limbs and axial muscles. Speech gradually deteriorates, with a mixed dysarthria and dysphonia. Dysphagia progresses in parallel with the dysarthria, and oral feeding eventually becomes impossible.</p><p>Approximately one third of individuals with NPC have partial and/or generalized seizures. Epilepsy may be refractory to medical therapy in some cases. Seizures usually improve if the child's survival is prolonged, this improvement presumably reflecting continued neuronal loss. About 20% of children with NPC have gelastic cataplexy, a sudden loss of muscle tone evoked by a strong emotional (humorous) stimulus. This can be disabling in those children who experience daily multiple attacks during which injuries may occur.</p><p>Mild demyelinating peripheral neuropathy has been described in a child with otherwise typical late-infantile NPC [<a class="bk_pop" href="#npc.REF.zafeiriou.2003.242">Zafeiriou et al 2003</a>]. This finding is likely a rare manifestation of NPC because prospective nerve conduction studies in a cohort of 41 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals participating in a clinical trial of miglustat have identified only one case to date [Patterson, personal communication (2006)].</p><p>Polysomnographic and biochemical studies have demonstrated disturbed sleep and variable reduction in cerebrospinal fluid hypocretin concentration in individuals with NPC, suggesting that the disease could have a specific impact on hypocretin-secreting cells of the hypothalamus [<a class="bk_pop" href="#npc.REF.kanbayashi.2003.52">Kanbayashi et al 2003</a>, <a class="bk_pop" href="#npc.REF.vankova.2003.427">Vankova et al 2003</a>].</p><p>Death from aspiration pneumonia usually occurs in the late second or third decade [<a class="bk_pop" href="#npc.REF.walterfang.2012b.76">Walterfang et al 2012b</a>].</p><p><b>Adolescent and adult presentations.</b> Adolescents or adults may present with neurologic disease as described in the preceding section, albeit with a much slower rate of progression. The author has seen one individual who survived into the seventh decade, having first developed symptoms 25 years earlier. Older individuals may also present with apparent psychiatric illness [<a class="bk_pop" href="#npc.REF.imrie.2002.491">Imrie et al 2002</a>, <a class="bk_pop" href="#npc.REF.josephs.2003.528">Josephs et al 2003</a>], sometimes appearing to have major depression or schizophrenia. The psychiatric manifestations may overshadow neurologic signs, although the latter can usually be detected with careful examination. An adult presenting with bipolar disorder has been described [<a class="bk_pop" href="#npc.REF.sullivan.2005.1021">Sullivan et al 2005</a>].</p><p>A German report describes two individuals with adult-onset dementia associated with frontal lobe atrophy and no visceral manifestations, as is common in adult-onset disease [<a class="bk_pop" href="#npc.REF.kl_nemann.2002.743">Kl&#x000fc;nemann et al 2002</a>].</p><p><b>Imaging.</b> MRI of the brain is usually normal until the late stages of the illness. At that time, marked atrophy of the superior/anterior cerebellar vermis, thinning of the corpus callosum, and mild cerebral atrophy may be seen. Increased signal in the periatrial white matter, reflecting secondary demyelination, may also occur. In one adult, areas of confluent white matter signal hyperintensity mimicked multiple sclerosis [<a class="bk_pop" href="#npc.REF.grau.1997.552">Grau et al 1997</a>]. Quantitative MRI studies in adults with NPC have found widespread gray and white matter abnormalities [<a class="bk_pop" href="#npc.REF.walterfang.2010.49">Walterfang et al 2010</a>], and reduction in callosal volume as the disease progresses [<a class="bk_pop" href="#npc.REF.walterfang.2011.1340">Walterfang et al 2011</a>]. In addition, the pontine:midbrain ratio correlates with oculomotor function and disease severity [<a class="bk_pop" href="#npc.REF.walterfang.2012a.462">Walterfang et al 2012a</a>].</p><p>Studies of magnetic resonance spectroscopy (MRS) suggested that MRS may be a more sensitive imaging technique in NPC than standard MRI [<a class="bk_pop" href="#npc.REF.tedeschi.1998.72">Tedeschi et al 1998</a>]. A French group has reported improvement in MRS parameters with miglustat therapy [<a class="bk_pop" href="#npc.REF.galanaud.2009.55">Galanaud et al 2009</a>].</p><p><b>Heterozygotes.</b> A recent report described an <i>NPC1</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> with tremor that the authors attributed to the mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#npc.REF.josephs.2004.2189">Josephs et al 2004</a>]. This observation notwithstanding, the question of manifesting heterozygotes must remain moot pending systematic prospective studies.</p></div><div id="npc.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b><i>NPC1.</i></b> In the approximately 200 pathogenic variants described in <i>NPC1</i> [<a class="bk_pop" href="#npc.REF.scott.2004.8">Scott &#x00026; Ioannou 2004</a>, <a class="bk_pop" href="#npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</a>], <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation is limited because most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are compound heterozygotes; and correlation of the trafficking defects demonstrable in culture and the clinical phenotype is poor. Nonetheless, some correlations have been possible for <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> variants and the more common variants in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state:</p><ul><li class="half_rhythm"><div>One international study documented phenotypes associated with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> leading to a <a class="figpopup" href="/books/NBK1296/table/npc.T.npc1_variants_discussed_in_this_ge/?report=objectonly" target="object" rid-figpopup="fignpcTnpc1variantsdiscussedinthisge" rid-ob="figobnpcTnpc1variantsdiscussedinthisge">p.Ile1061Thr</a> change in the Hispanic population in the upper Rio Grande Valley in the southwestern US, and in the UK and France. No individuals with this pathogenic variant had the severe infantile form of NPC [<a class="bk_pop" href="#npc.REF.millat.1999.1321">Millat et al 1999</a>].</div></li><li class="half_rhythm"><div>More recently, the same group found that premature-termination-codon variants, variants involving the sterol-sensing <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, and <a class="figpopup" href="/books/NBK1296/table/npc.T.npc1_variants_discussed_in_this_ge/?report=objectonly" target="object" rid-figpopup="fignpcTnpc1variantsdiscussedinthisge" rid-ob="figobnpcTnpc1variantsdiscussedinthisge">p.Ala1054Thr</a> in the cysteine-rich luminal loop of <i>NPC1</i> are associated with early-onset disease and classic biochemical changes [<a class="bk_pop" href="#npc.REF.millat.2001b.1373">Millat et al 2001b</a>].</div></li><li class="half_rhythm"><div>All mutated alleles that correlate with the biochemical "variant" <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are clustered in the cysteine-rich luminal loop [<a class="bk_pop" href="#npc.REF.millat.2001b.1373">Millat et al 2001b</a>].</div></li><li class="half_rhythm"><div>A study of 40 unrelated individuals of Spanish descent suggested that those <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK1296/table/npc.T.npc1_variants_discussed_in_this_ge/?report=objectonly" target="object" rid-figpopup="fignpcTnpc1variantsdiscussedinthisge" rid-ob="figobnpcTnpc1variantsdiscussedinthisge">p.Gln775Pro</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> showed a severe infantile neurologic form and those homozygous for the <a class="figpopup" href="/books/NBK1296/table/npc.T.npc1_variants_discussed_in_this_ge/?report=objectonly" target="object" rid-figpopup="fignpcTnpc1variantsdiscussedinthisge" rid-ob="figobnpcTnpc1variantsdiscussedinthisge">p.Cys177Tyr</a> pathogenic variant, a late-infantile clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</a>].</div></li></ul><p><b><i>NPC2.</i></b> Of the five pathogenic variants identified by <a class="bk_pop" href="#npc.REF.millat.2001b.1373">Millat et al [2001b]</a>, all but <a class="figpopup" href="/books/NBK1296/table/npc.T.npc2_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fignpcTnpc2pathogenicvariantsdiscussed" rid-ob="figobnpcTnpc2pathogenicvariantsdiscussed">c.190+5G&#x0003e;A</a> were associated with a severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, characterized by pulmonary infiltrates, respiratory failure, and death by age four years:</p><ul><li class="half_rhythm"><div>The two individuals with <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants had juvenile-onset disease and prolonged survival.</div></li><li class="half_rhythm"><div>Adult-onset disease with frontal lobe atrophy has been described in association with a <a class="figpopup" href="/books/NBK1296/table/npc.T.npc2_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fignpcTnpc2pathogenicvariantsdiscussed" rid-ob="figobnpcTnpc2pathogenicvariantsdiscussed">p.Val39Met</a> variant in <i>NPC2</i> [<a class="bk_pop" href="#npc.REF.kl_nemann.2002.743">Kl&#x000fc;nemann et al 2002</a>].</div></li><li class="half_rhythm"><div>Neonatal or infantile onset and death in early childhood were reported in children <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for <a class="figpopup" href="/books/NBK1296/table/npc.T.npc2_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fignpcTnpc2pathogenicvariantsdiscussed" rid-ob="figobnpcTnpc2pathogenicvariantsdiscussed">p.Gln45Ter</a>, <a class="figpopup" href="/books/NBK1296/table/npc.T.npc2_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fignpcTnpc2pathogenicvariantsdiscussed" rid-ob="figobnpcTnpc2pathogenicvariantsdiscussed">p.Cys47Ter</a>, and <a class="figpopup" href="/books/NBK1296/table/npc.T.npc2_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fignpcTnpc2pathogenicvariantsdiscussed" rid-ob="figobnpcTnpc2pathogenicvariantsdiscussed">p.Cys99Arg</a>, whereas prolonged survival into middle adult life has been seen in those homozygous for p.Val39Met and <a class="figpopup" href="/books/NBK1296/table/npc.T.npc2_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="fignpcTnpc2pathogenicvariantsdiscussed" rid-ob="figobnpcTnpc2pathogenicvariantsdiscussed">p.Ser67Pro</a> [<a class="bk_pop" href="#npc.REF.chikh.2005.20">Chikh et al 2005</a>].</div></li></ul></div><div id="npc.Nomenclature"><h3>Nomenclature</h3><p>The older literature on NPC is bedeviled by the large number of terms used to describe individuals now known to have the disease. These include juvenile dystonic idiocy, juvenile dystonic lipidosis, juvenile NPC, neurovisceral lipidosis with vertical supranuclear gaze palsy, Neville-lake disease, sea-blue histiocytosis, lactosylceramidosis, and DAF (<i>d</i>owngaze paralysis, <i>a</i>taxia, <i>f</i>oam cells) syndrome.</p><p>The term Niemann-Pick disease type D describes a genetic isolate from Nova Scotia that is biochemically and clinically indistinguishable from NPC and that also results from mutation of <i>NPC1</i>.</p><p>The terms NPC1 and NPC2 are now preferred because they accurately describe the mutated genes responsible for the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div><div id="npc.Prevalence"><h3>Prevalence</h3><p>The prevalence of NPC has been estimated at 1:150,000 in western Europe. The incidence of NPC in France has been calculated at about 1:120,000, based on the number of postnatally diagnosed cases in a ten-year period versus the number of births during that same time period. When prenatal cases that did not result in a live-born infant were included, a slightly higher incidence of 1:100,000 was found [<a class="bk_pop" href="#npc.REF.vanier.2010.16">Vanier 2010</a>]. The prevalence of NPC in early life is probably underestimated, owing to its nonspecific presentations. The overall prevalence is likely higher than the calculated incidence, owing to relatively prolonged survival in those with later-onset disease, although no comprehensive data are available.</p><p>Acadians in Nova Scotia, individuals of Hispanic descent in parts of Colorado and New Mexico, and a Bedouin group in Israel represent genetic isolates with a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a>.</p></div></div><div id="npc.Genetically_Related_Allelic_Disorder"><h2 id="_npc_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with mutation of <i>NPC1</i> or <i>NPC2</i>.</p></div><div id="npc.Differential_Diagnosis"><h2 id="_npc_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Neonatal and infantile presentations</b> include biliary atresia, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> infections, <a href="/books/n/gene/alpha1-a/">alpha-1-antitrypsin deficiency</a>, <a href="/books/n/gene/tyrosinemia/">tyrosinemia</a>, malignancies (leukemia, lymphoma, histiocytosis), other storage diseases (e.g., <a href="/books/n/gene/gaucher/">Gaucher disease</a>, <a href="/books/n/gene/npab/">Niemann-Pick disease type A</a>, <a href="/books/n/gene/npab/">Niemann-Pick disease type B</a>), and infections (e.g., TORCH). A study from Colorado found that 27% of infants initially diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> neonatal cholestasis and 8% of all infants with cholestasis had NPC [<a class="bk_pop" href="#npc.REF.yerushalmi.2002.44">Yerushalmi et al 2002</a>]. Although this cohort may have been enriched by a local Hispanic genetic isolate, the importance of Niemann-Pick disease type C (NPC) as a cause of jaundice in infants is appropriately emphasized.</p><p><b>Childhood presentations</b> include pineal region or midbrain tumors causing dorsal midbrain syndrome, hydrocephalus, <a href="/books/n/gene/tay-sachs/">GM2 gangliosidosis</a>, <a href="/books/n/gene/mt-overview/">mitochondrial diseases</a>, <a href="/books/n/gene/msud/">maple syrup urine disease</a>, attention-deficit disorder, learning disabilities, absence seizures, other dementing illnesses, <a href="/books/n/gene/dystonia/">idiopathic torsion dystonia</a>, <a href="/books/n/gene/drd/">dopa-responsive dystonia</a>, <a href="/books/n/gene/wilson/">Wilson disease</a>, amino acidurias and organic acidopathies (e.g., glutaric aciduria type 1), pseudodementia (depressive disorder), neuronal ceroid-lipofuscinosis, subacute sclerosing panencephalitis (see <a href="/books/n/gene/narp/">Mitochondrial DNA-Associated Leigh Syndrome and NARP</a>), HIV encephalopathy, sleep disorders, syncope, and periodic paralysis (see <a href="/books/n/gene/hyper-pp/">Hyperkalemic Periodic Paralysis Type 1</a>, <a href="/books/n/gene/hpp/">Hypokalemic Periodic Paralysis</a>).</p><p><b>Adolescent and adult presentations</b> include <a href="/books/n/gene/alzheimer/">Alzheimer disease</a>, Pick disease (an adult-onset disorder with dementia associated with characteristic neuronal inclusions called Pick bodies, not related to Niemann-Pick disease), frontotemporal dementias, Steele-Richardson-Olzewski syndrome (also known as progressive supranuclear palsy), late-onset lysosomal storage diseases, syphilis, HIV dementia, and primary psychiatric illnesses.</p></div><div id="npc.Management"><h2 id="_npc_Management_">Management</h2><p>Clinical management guidelines for Niemann-Pick C have been published [<a class="bk_pop" href="#npc.REF.patterson.2012.330">Patterson et al 2012</a>].</p><div id="npc.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Niemann-Pick disease type C (NPC), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Assessment of ability to walk and transfer, manage secretions, and communicate (language, speech, and hearing)</div></li><li class="half_rhythm"><div>For individuals with hepatosplenomegaly, complete blood count and tests of hepatic function</div></li><li class="half_rhythm"><div>MRI of the head; usually performed in the course of the workup and usually normal until the disease is advanced</div></li><li class="half_rhythm"><div>Consideration of EEG and sleep studies if the history suggests seizures or sleep disturbances</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="npc.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No curative therapy for NPC exists.</p><p>Symptomatic therapy may be at least partially effective in the management of seizures, dystonia, and cataplexy.</p><p>If disordered sleep is identified, a nocturnal sedative may be indicated. In complex cases, formal evaluation by a sleep specialist should be considered.</p><p>Bronchoalveolar lavage has been described as effective in improving function in one child with pulmonary infiltrates [<a class="bk_pop" href="#npc.REF.palmeri.2005.171">Palmeri et al 2005</a>].</p><p>General supportive care, including respite for primary caregivers, is crucial to the maintenance of the family unit in the face of this devastating illness.</p></div><div id="npc.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Chest physical therapy with aggressive bronchodilation and antibiotic therapy for intercurrent infection appears beneficial, although no systematic study has been performed.</p><p>Individuals whose mobility is compromised should have a regular bowel program to prevent severe constipation, which may present as increased seizure frequency or increased spasticity in some impaired individuals with NPC.</p><p>Physical therapy is indicated to maintain mobility as long as possible.</p><p>Swallowing must be monitored to allow consideration of gastrostomy tube placement when aspiration or nutritional compromise is imminent.</p></div><div id="npc.Surveillance"><h3>Surveillance</h3><p>General pediatric evaluations, with special attention to pulmonary function, swallowing, bowel habit, and mood (for occult depression), are appropriate at six-month intervals for most juvenile and adult <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Sleep disturbances are common in NPC; the affected individual or caregiver should be questioned regarding sleep hygiene as a part of regular evaluation.</p><p>Annual psychometric testing may be helpful in arranging appropriate school or work placement.</p><p>Teenagers and adults with motor or sensory impairments who are driving should be monitored at six- to 12-month intervals to ensure that they do not present a risk to themselves or others.</p></div><div id="npc.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Drugs that cause excessive salivation or that may exacerbate seizures directly by interacting with antiepileptic drugs should be avoided.</p><p>Alcohol as well as many drugs exacerbate ataxia and should be avoided.</p></div><div id="npc.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#npc.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="npc.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Inhibition of glycosphingolipid synthesis by n-butyldeoxynojirimycin has been shown to delay onset and prolong survival in both murine and feline models of NPC [<a class="bk_pop" href="#npc.REF.zervas.2001.1283">Zervas et al 2001</a>, <a class="bk_pop" href="#npc.REF.stein.2012.434">Stein et al 2012</a>]. A prospective trial of the same agent showed evidence of stabilization or benefit in some individuals [<a class="bk_pop" href="#npc.REF.patterson.2007.765">Patterson et al 2007</a>]. Subsequent clinical studies have supported a role of miglustat in stabilizing NPC [<a class="bk_pop" href="#npc.REF.pineda.2009.243">Pineda et al 2009</a>, <a class="bk_pop" href="#npc.REF.wraith.2009.877">Wraith &#x00026; Imrie 2009</a>, <a class="bk_pop" href="#npc.REF.patterson.2010.300">Patterson et al 2010</a>, <a class="bk_pop" href="#npc.REF.pineda.2010.358">Pineda et al 2010</a>, <a class="bk_pop" href="#npc.REF.wraith.2010.351">Wraith et al 2010</a>, <a class="bk_pop" href="#npc.REF.fecarotta.2011.540">Fecarotta et al 2011</a>, <a class="bk_pop" href="#npc.REF.di_rocco.2012.40">Di Rocco et al 2012</a>, <a class="bk_pop" href="#npc.REF.h_ron.2012.36">H&#x000e9;ron et al 2012</a>, <a class="bk_pop" href="#npc.REF.chien.2013.129">Chien et al 2013</a>]. The agent has been approved for the management of neurologic manifestations of NPC in several countries, not including the United States. A recent review of the published literature on miglustat, including clinical, biomarker, and imaging measures, supported the efficacy of this agent in ameliorating the course of Niemann-Pick disease, type C [<a class="bk_pop" href="#npc.REF.pineda.2018.140">Pineda et al 2018</a>].</p><p>Laboratory studies of cellular and murine models of NPC have raised the possibility of small-molecule therapies to interdict pathways triggering apoptosis and related routes to cell death and dysfunction [<a class="bk_pop" href="#npc.REF.patterson.2004.77">Patterson &#x00026; Platt 2004</a>]; to date, these have not proceeded to clinical trials.</p><p>Preliminary studies of neurosteroid replacement therapy with allopregnanolone in NPC mice suggested similar improvements in survival to those seen with n-butyldeoxynojirimycin, provided that the steroid is administered early in postnatal life [<a class="bk_pop" href="#npc.REF.mellon.2002.35">Mellon &#x00026; Griffin 2002</a>]. Subsequent studies have shown that the active agent was the vehicle, hydroxypropyl beta cyclodextrin, which has shown dramatic effects in the murine model of NPC [<a class="bk_pop" href="#npc.REF.abimosleh.2009.19316">Abi-Mosleh et al 2009</a>, <a class="bk_pop" href="#npc.REF.davidson.2009.e6951">Davidson et al 2009</a>, <a class="bk_pop" href="#npc.REF.ramirez.2010.309">Ramirez et al 2010</a>, <a class="bk_pop" href="#npc.REF.rosenbaum.2010.5477">Rosenbaum et al 2010</a>, <a class="bk_pop" href="#npc.REF.ward.2010.52">Ward et al 2010</a>, <a class="bk_pop" href="#npc.REF.vance.2011.204">Vance &#x00026; Peake 2011</a>, <a class="bk_pop" href="#npc.REF.peake.2012.9290">Peake &#x00026; Vance 2012</a>].</p><p>Studies in tissue culture have demonstrated that direct or indirect overexpression of the GTPase Rab 9 reverses the NPC <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#npc.REF.choudhury.2002.1541">Choudhury et al 2002</a>, <a class="bk_pop" href="#npc.REF.walter.2003.243">Walter et al 2003</a>]. Although not yet applicable in human trials, this finding suggests the existence of alternate pathways for mobilization of endosomal cargoes that are potential targets for small-molecule therapies.</p><p>Treatment of certain NPC fibroblast cell lines with an HDAC inhibitor produced marked reduction of cholesterol storage [<a class="bk_pop" href="#npc.REF.pipalia.2011.5620">Pipalia et al 2011</a>]; a clinical trial is being considered.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="npc.Other"><h3>Other</h3><p>In the C57 murine model of NPC, all treatment modalities, including bone marrow transplantation, combined bone marrow and liver transplantation, and aggressive cholesterol-lowering therapy, have proven ineffective.</p><p>Although a trial of cholesterol-lowering agents showed that the amount of free cholesterol in the liver of individuals with NPC could be reduced by the administration of cholestyramine, lovastatin, and nicotinic acid [<a class="bk_pop" href="#npc.REF.patterson.1993.61">Patterson et al 1993</a>], there is no evidence that this approach modifies the neurologic progression of NPC.</p><p>Liver transplantation in humans corrects hepatic dysfunction but does not ameliorate the neurologic disease.</p></div></div><div id="npc.Genetic_Counseling"><h2 id="_npc_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="npc.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Niemann-Pick disease type C (NPC) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="npc.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Parents of children with NPC are obligate heterozygotes.</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> usually runs true in families; that is, if the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has early-onset disease, subsequent affected individuals will have a similar clinical course. In rare cases, a proband and subsequent offspring have had different clinical presentations.</div></li><li class="half_rhythm"><div>Sibs younger than the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have the disease but be asymptomatic. Assuming that the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> runs true in the family, a proband's unaffected older sibs have a 2/3 risk of carrying one abnormal <i>NPC</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with NPC will inherit one abnormal <i>NPC</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> from the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent and are thus obligate heterozygotes.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of a proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="npc.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Biochemical testing is unreliable in defining the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state, owing to significant overlaps with findings seen in controls.</p><p>Molecular genetic analysis of <i>NPC1</i> or <i>NPC2</i> may be used for <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> if pathogenic variants in <i>NPC1</i> or <i>NPC2</i> have been identified in the family.</p></div><div id="npc.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="npc.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>If both pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member [<a class="bk_pop" href="#npc.REF.vanier.2002.630">Vanier 2002</a>], prenatal testing for a pregnancy at 25% risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for NPC are possible.</p></div></div><div id="npc.Resources"><h2 id="_npc_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Ara Parseghian Medical Research Foundation</b></div><div>3530 East Campo Abierto</div><div>Suite 105</div><div>Tucson AZ 85718-3327</div><div><b>Phone:</b> 520-577-5106</div><div><b>Fax:</b> 520-577-5212</div><div><b>Email:</b> victory@parseghian.org</div><div><a href="http://www.parseghian.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.parseghian.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Niemann-Pick%20disease%20Type%20C&#x00026;parent=Metabolic%20Disorders&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Niemann-Pick Disease Type C</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=niemannpickdisease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Niemann-Pick disease</a></div></li><li class="half_rhythm"><div><b>National Niemann-Pick Disease Foundation (NNPDF)</b></div><div>401 Madison Avenue</div><div>Suite B</div><div>PO Box 49</div><div>Fort Atkinson WI 53538</div><div><b>Phone:</b> 877-287-3672 (toll-free); 920-563-0930</div><div><b>Fax:</b> 920-563-0931</div><div><b>Email:</b> nnpdf@nnpdf.org</div><div><a href="http://www.nnpdf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nnpdf.org</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22176/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Niemann-Pick disease</a></div></li><li class="half_rhythm"><div><b>Niemann-Pick Disease Group - UK</b></div><div>Suite 2, Vermont House, Concord</div><div>Washington Tyne and Wear NE37 2SQ</div><div>United Kingdom</div><div><b>Phone:</b> +44-0191-415-0693</div><div><b>Email:</b> info@npuk.org</div><div><a href="https://www.npuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">https://www.npuk.org/</a></div></li><li class="half_rhythm"><div><b>Canadian MPS Society</b></div><div>#218-2055 Commercial Drive</div><div>Vancouver British Columbia V5N 0C7</div><div>Canada</div><div><b>Phone:</b> 800-667-1846; 604-924-5130</div><div><b>Email:</b> info@mpssociety.ca</div><div><a href="http://www.mpssociety.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mpssociety.ca</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: Sterol and Isoprenoid Research Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/stair" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RDCRN Patient Contact Registry</a></div></li></ul></div><div id="npc.Molecular_Genetics"><h2 id="_npc_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="npc.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Niemann-Pick Disease Type C: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1296/table/npc.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__npc.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_npc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_npc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_npc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_npc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_npc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_npc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_npc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4864" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NPC1</i></a></td><td headers="hd_b_npc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4864" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">18q11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_npc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15118" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NPC intracellular cholesterol transporter 1</a></td><td headers="hd_b_npc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/NPC1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NPC1 database</a></td><td headers="hd_b_npc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NPC1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NPC1</a></td><td headers="hd_b_npc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NPC1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NPC1</a></td></tr><tr><td headers="hd_b_npc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10577" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NPC2</i></a></td><td headers="hd_b_npc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10577" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_npc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P61916" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NPC intracellular cholesterol transporter 2</a></td><td headers="hd_b_npc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/NPC2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NPC2 database</a></td><td headers="hd_b_npc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NPC2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NPC2</a></td><td headers="hd_b_npc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NPC2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NPC2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="npc.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="npc.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Niemann-Pick Disease Type C (<a href="/omim/257220,601015,607623,607625" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1296/table/npc.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__npc.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/257220" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">257220</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NIEMANN-PICK DISEASE, TYPE C1; NPC1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601015" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601015</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NPC2 GENE; NPC2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607623" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607623</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NPC1 GENE; NPC1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607625" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607625</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NIEMANN-PICK DISEASE, TYPE C2; NPC2</td></tr></tbody></table></div></div><div id="npc.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The central defect in NPC is in intracellular trafficking of lipids, as opposed to the lysosomal hydrolase deficiency characteristic of the classic lysosomal storage diseases (LSDs). Notwithstanding, all LSDs are marked by the accumulation of multiple lipid species in the lysosomes, and secondary trafficking impairment occurs in disorders with primary hydrolase deficiencies. In NPC, cholesterol accumulates in great excess in the lysosomes and may lead to a deficiency in membrane cholesterol. Given the critical role of cholesterol in maintaining membrane order, this downstream deficiency could conceivably play a role in membrane dysfunction, and possibly in the triggering of apoptosis [<a class="bk_pop" href="#npc.REF.mukherjee.2004.28">Mukherjee &#x00026; Maxfield 2004</a>].</p><p>Glycosphingolipid accumulation is characteristic of the neuropathology of NPC; animal studies have demonstrated that GM2 accumulation is associated with ectopic dendritogenesis and meganeurite formation, which &#x02013; together with the formation of neurofibrillary tangles (cholesterol dysregulation) and neuroaxonal dystrophy &#x02013; are likely anatomic substrates for neurologic dysfunction [<a class="bk_pop" href="#npc.REF.walkley.2004.48">Walkley &#x00026; Suzuki 2004</a>].</p><p>Trafficking studies suggest that NPC2 binds cholesterol in the luminal space of the late-endosome/lysosome and transports it to the delimiting membrane. NPC resides in the membrane of the late endosomes and is shuttled between that compartment and the plasma membrane and other internal sites. It remains to be determined how these two molecules interact, how they sense the presence and concentration of lipids, and why NPC1 accompanies its vesicular cargo to its destination [<a class="bk_pop" href="#npc.REF.liscum.2004.22">Liscum &#x00026; Sturley 2004</a>]. One model proposes that initial sphongosone accumulation leads to lysosomal calcium deregulation, which triggers the cascade of secondary effects characteristic of NPC [<a class="bk_pop" href="#npc.REF.lloydevans.2008.1247">Lloyd-Evans et al 2008</a>, <a class="bk_pop" href="#npc.REF.tang.2010.132">Tang et al 2010</a>, <a class="bk_pop" href="#npc.REF.lloydevans.2011.200">Lloyd-Evans &#x00026; Platt 2011</a>].</p><div id="npc.NPC1"><h4><i>NPC1</i></h4><p><b>Gene structure.</b>
<i>NPC1</i> contains 25 exons, varying in size from 74 to 788 bp, spread over 47 kb [<a class="bk_pop" href="#npc.REF.morris.1999.493">Morris et al 1999</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1296/#npc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> More than 50 <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> polymorphisms have been described; the most prevalent are listed in <a class="figpopup" href="/books/NBK1296/table/npc.T.npc1_variants_discussed_in_this_ge/?report=objectonly" target="object" rid-figpopup="fignpcTnpc1variantsdiscussedinthisge" rid-ob="figobnpcTnpc1variantsdiscussedinthisge">Table 2</a> [<a class="bk_pop" href="#npc.REF.millat.2005.220">Millat et al 2005</a>].</p><p><b>Pathogenic variants.</b> Approximately 200 pathogenic variants have been described in <i>NPC1</i> [<a class="bk_pop" href="#npc.REF.scott.2004.8">Scott &#x00026; Ioannou 2004</a>, <a class="bk_pop" href="#npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</a>].</p><p>A study of 143 unrelated individuals with NPC identified 121 different pathogenic variants in 251 of 286 disease alleles, an overall detection rate of 88% [<a class="bk_pop" href="#npc.REF.park.2003.313">Park et al 2003</a>]. Cases negative for pathogenic variants showed a high proportion of equivocal results in complementation studies, raising the possibilities of (1) a third complementation group for NPC or (2) nonspecificity of NPC biochemical testing. The region between amino acids 1038 and 1253 (which includes the Patched 1 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>) and the region in amino acids identical to the NPC1 homolog NPC1L1 were hot spots for mutation.</p><p>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are compound heterozygotes for single-nucleotide variants producing <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> (~70% of pathogenic variants overall) [<a class="bk_pop" href="#npc.REF.millat.2005.220">Millat et al 2005</a>] and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants; deletions and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants have also been reported.</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> leading to a p.Gly992Trp change has been identified in several individuals in the Acadian population of Nova Scotia [<a class="bk_pop" href="#npc.REF.greer.1998.52">Greer et al 1998</a>] and in Portugal; a p.Gly992Arg variant has been described in France [<a class="bk_pop" href="#npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</a>] (<a class="figpopup" href="/books/NBK1296/table/npc.T.npc1_variants_discussed_in_this_ge/?report=objectonly" target="object" rid-figpopup="fignpcTnpc1variantsdiscussedinthisge" rid-ob="figobnpcTnpc1variantsdiscussedinthisge">Table 2</a>).</p><p>A Spanish report found that individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the p.Gln775Pro variant had a severe infantile neurologic illness, and those with the p.Cys177Tyr variant had a late-infantile clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</a>].</p><p>The p.Ile1061Thr variant accounts for 15%-20% of mutated alleles in western Europe and the US, followed by p.Pro1007Ala [<a class="bk_pop" href="#npc.REF.millat.2005.220">Millat et al 2005</a>].</p><div id="npc.T.npc1_variants_discussed_in_this_ge" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>NPC1</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1296/table/npc.T.npc1_variants_discussed_in_this_ge/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__npc.T.npc1_variants_discussed_in_this_ge_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Benign</b></td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.709C&#x0003e;T</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro237Ser</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_4" rowspan="13" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=133930789" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000271<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=4557803" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000262<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1926C&#x0003e;G</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile642Met</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2572A&#x0003e;G</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile858Val</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2793C&#x0003e;T</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn93</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3797G&#x0003e;A</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1266Gln</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_1" rowspan="8" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.530G&#x0003e;A</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys177Tyr</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2324A&#x0003e;C</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln775Pro</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2974G&#x0003e;T</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly992Trp</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2974G&#x0003e;C</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly992Arg</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2974G&#x0003e;A</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly992Arg</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3019C&#x0003e;G</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro1007Ala</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3160G&#x0003e;A</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala1054Thr</td></tr><tr><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3182T&#x0003e;C</td><td headers="hd_h_npc.T.npc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile1061Thr</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>NPC1</i> protein product is an integral membrane protein with 13 transmembrane domains, which appears to be localized to a late endosomal compartment. Its function is as yet imperfectly understood, but it clearly plays a central role in modulating intracellular sorting of cholesterol and glycosphingolipids [<a class="bk_pop" href="#npc.REF.neufeld.1999.9627">Neufeld et al 1999</a>]. <a class="bk_pop" href="#npc.REF.wojtanik.2003.14850">Wojtanik &#x00026; Liscum [2003]</a> have shown that in the cells of individuals with NPC1, LDL cholesterol traffics directly through endosomes to lysosomes, bypassing the plasma membrane, and is trapped there because of dysfunctional NPC1. NPC1 appears to serve this function, at least in part, by maintaining the small size of cholesterol-containing lipid droplets in the cell [<a class="bk_pop" href="#npc.REF.wiegand.2003.782">Wiegand et al 2003</a>]. <a class="bk_pop" href="#npc.REF.strauss.2002.947">Strauss et al [2002]</a> have suggested that NPC1 may act cooperatively with NPC2 and MLN64 in an ordered sequence to effect intracellular sterol movement. Sterol storage in fibroblasts correlates with oxysterol levels; administration of oxysterols corrects the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in cells with the p.Ile1061Thr <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, suggesting that NPC1 and NPC2 regulate intracellular sterol homeostasis via oxysterols [<a class="bk_pop" href="#npc.REF.frolov.2003.25517">Frolov et al 2003</a>]. Domains 3-7 of the NPC1 protein have homology to the sterol-sensing domains of SCAP and HMG CoA reductase, and other domains are homologous to the <i>Drosophila</i> morphogen patched [<a class="bk_pop" href="#npc.REF.carstea.1997.228">Carstea et al 1997</a>]. Studies in cultured fibroblasts have shown that specific single-nucleotide variants in the sterol-sensing <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> can induce either loss of function (p.Pro692Ser) or gain of function (p.Asp787Asn, p.Leu657Phe) in trafficking to the plasma membrane and ER [<a class="bk_pop" href="#npc.REF.millard.2005.28581">Millard et al 2005</a>]. The overrepresentation of pathogenic variants in these domains further emphasizes their key roles in the function of the protein (see <a href="#npc.NPC1"><b><i>NPC1</i></b></a><b>,</b>
<b>Pathogenic variants</b>). NPC1 appears to mediate fatty acid transport in <i>E coli</i>; but this is not the case in human NPC fibroblasts, where fatty acid trafficking is normal [<a class="bk_pop" href="#npc.REF.passeggio.2005.10333">Passeggio &#x00026; Liscum 2005</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Deficiency of the <i>NPC1</i> gene product leads to a complex pattern of intracellular lipid storage, including excess unesterified cholesterol, GM2 and GM3 gangliosides, lactosylceramide, glucosylceramide, and lysobisphosphatidic acid. The accumulation of these substrates is thought to reflect impaired intracellular trafficking mediated by the NPC1 and NPC2 proteins respectively [<a class="bk_pop" href="#npc.REF.watari.1999.805">Watari et al 1999</a>, <a class="bk_pop" href="#npc.REF.liscum.2004.22">Liscum &#x00026; Sturley 2004</a>, <a class="bk_pop" href="#npc.REF.mukherjee.2004.28">Mukherjee &#x00026; Maxfield 2004</a>].</p></div><div id="npc.NPC2"><h4><i>NPC2</i></h4><p><b>Gene structure.</b>
<i>NPC2</i> has five exons and a single transcript of 0.9 kb in all tissues. It has been mapped to 14q24.3 [<a class="bk_pop" href="#npc.REF.chikh.2004.220">Chikh et al 2004</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1296/#npc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Two individuals were originally described with pathogenic variants in <i>NPC2</i> [<a class="bk_pop" href="#npc.REF.naureckiene.2000.2298">Naureckiene et al 2000</a>]. One individual was <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for c.58G&#x0003e;T in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1, and the other was a compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> for c.58G&#x0003e;T and c.332delA. A comprehensive study of eight families with NPC2 found five pathogenic variants in the 16 mutated alleles identified (p.Glu20Ter, p.Glu118Ter, c.27delG, c.190_5G&#x0003e;A, p.Ser67Pro) [<a class="bk_pop" href="#npc.REF.millat.2001a.1013">Millat et al 2001a</a>]. Except for c.27delG, the variants were all homozygous. More recent studies have identified a total of 13 pathogenic variants, including five <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and six that code for a premature stop codon [<a class="bk_pop" href="#npc.REF.chikh.2005.20">Chikh et al 2005</a>].</p><div id="npc.T.npc2_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>NPC2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1296/table/npc.T.npc2_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__npc.T.npc2_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.58G&#x0003e;T</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu20Ter</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_3" rowspan="10" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=29171756" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006432<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=5453678" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006423<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.115G&#x0003e;A</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val39Met</td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.133C&#x0003e;T</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln45Ter</td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.141C&#x0003e;A</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys47Ter</td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.199T&#x0003e;C</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser67Pro</td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.295T&#x0003e;C</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys99Arg</td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.332delA</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn111IlefsTer5</td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.352G&#x0003e;T</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu118Ter</td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.27delG</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala12ArgfsTer23</td></tr><tr><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.190+5G&#x0003e;A<br />(IVS2+5G&#x0003e;A)</td><td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="npc.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>NPC2</i> protein product is a 132-amino acid glycoprotein that is expressed in all tissues examined, with the highest concentrations being found in epididymal fluid as well as in testis, kidney, and liver. NPC2 protein is soluble, binds cholesterol, and is able to partially reverse the lipid accumulation in NPC2 fibroblasts when added to the medium in culture. Added NPC2 has no effect on NPC1 fibroblasts in culture [<a class="bk_pop" href="#npc.REF.naureckiene.2000.2298">Naureckiene et al 2000</a>]. Different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> varying from 19 to 23 kd are distributed in a tissue-specific fashion, reflecting variable glycosylation [<a class="bk_pop" href="#npc.REF.vanier.2004.14">Vanier &#x00026; Millat 2004</a>]. Only the Asn58 residue needs to be glycosylated to ensure accurate targeting. NPC2 protein binds the mannose-6-phosphate receptor, and, in contrast, is not dependent on the presence of cholesterol for lysosomal targeting. NPC2 mainly colocalizes with LAMP1 but is also distributed to LAMP1-negative organelles [<a class="bk_pop" href="#npc.REF.vanier.2004.14">Vanier &#x00026; Millat 2004</a>].</p></div></div></div><div id="npc.References"><h2 id="_npc_References_">References</h2><div id="npc.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="npc.REF.abimosleh.2009.19316">Abi-Mosleh L, Infante RE, Radhakrishnan A, Goldstein JL, Brown MS. Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>:19316–21.</span> [<a href="/pmc/articles/PMC2780767/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2780767</span></a>] [<a href="/pubmed/19884502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19884502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.boustany.1990.177">Boustany RN, Kaye E, Alroy J. Ultrastructural findings in skin from patients with Niemann-Pick disease, type C. <span><span class="ref-journal">Pediatr Neurol. </span>1990;<span class="ref-vol">6</span>:177–83.</span> [<a href="/pubmed/2360958" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2360958</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.brady.1989.75">Brady RO, Filling-Katz MR, Barton NW, Pentchev PG. Niemann-Pick disease types C and D. <span><span class="ref-journal">Neurol Clin. </span>1989;<span class="ref-vol">7</span>:75–88.</span> [<a href="/pubmed/2646522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2646522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.carstea.1997.228">Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF 3rd, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O'Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. <span><span class="ref-journal">Science. </span>1997;<span class="ref-vol">277</span>:228–31.</span> [<a href="/pubmed/9211849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9211849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.chien.2013.129">Chien YH, Peng SF, Yang CC, Lee NC, Tsai LK, Huang AC, Su SC, Tseng CC, Hwu WL. Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C. <span><span class="ref-journal">J Inherit Metab Dis. </span>2013;<span class="ref-vol">36</span>:129–37.</span> [<a href="/pubmed/22476655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22476655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.chikh.2005.20">Chikh K, Rodriguez C, Vey S, Vanier MT, Millat G. Niemann-Pick type C disease: subcellular location and functional characterization of NPC2 proteins with naturally occurring missense mutations. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">26</span>:20–8.</span> [<a href="/pubmed/15937921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15937921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.chikh.2004.220">Chikh K, Vey S, Simonot C, Vanier MT, Millat G. Niemann-Pick type C disease: importance of N-glycosylation sites for function and cellular location of the NPC2 protein. <span><span class="ref-journal">Mol Genet Metab. </span>2004;<span class="ref-vol">83</span>:220–30.</span> [<a href="/pubmed/15542393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15542393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.choudhury.2002.1541">Choudhury A, Dominguez M, Puri V, Sharma DK, Narita K, Wheatley CL, Marks DL, Pagano RE. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. <span><span class="ref-journal">J Clin Invest. </span>2002;<span class="ref-vol">109</span>:1541–50.</span> [<a href="/pmc/articles/PMC151017/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC151017</span></a>] [<a href="/pubmed/12070301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12070301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.davidson.2009.e6951">Davidson CD, Ali NF, Micsenyi MC, Stephney G, Renault S, Dobrenis K, Ory DS, Vanier MT, Walkley SU. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. <span><span class="ref-journal">PloS One. </span>2009;<span class="ref-vol">4</span>:e6951.</span> [<a href="/pmc/articles/PMC2736622/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2736622</span></a>] [<a href="/pubmed/19750228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19750228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.di_rocco.2012.40">Di Rocco M, Dardis A, Madeo A, Barone R, Fiumara A. Early miglustat therapy in infantile Niemann-Pick disease type C. <span><span class="ref-journal">Pediatr Neurol. </span>2012;<span class="ref-vol">47</span>:40–3.</span> [<a href="/pubmed/22704015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22704015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.fecarotta.2011.540">Fecarotta S, Amitrano M, Romano A, Della Casa R, Bruschini D, Astarita L, Parenti G, Andria G. The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:540–7.</span> [<a href="/pubmed/21344635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21344635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.fernandezvalero.2005.245">Fernandez-Valero EM, Ballart A, Iturriaga C, Lluch M, Macias J, Vanier MT, Pineda M, Coll MJ. Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">68</span>:245–54.</span> [<a href="/pubmed/16098014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16098014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.frolov.2003.25517">Frolov A, Zielinski SE, Crowley JR, Dudley-Rucker N, Schaffer JE, Ory DS. NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:25517–25.</span> [<a href="/pubmed/12719428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12719428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.galanaud.2009.55">Galanaud D, Tourbah A, Leh&#x000e9;ricy S, Leveque N, Heron B, Billette de Villemeur T, Guffon N, Feillet F, Baumann N, Vanier MT, Sedel F. 24-month treatment with miglustat of three patients with Niemann-Pick disease type C: follow up using brain spectroscopy. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">96</span>:55–8.</span> [<a href="/pubmed/19013089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19013089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.geberhiwot.2018.50">Geberhiwot T, Moro A, Dardis A, Ramaswami U, Sirrs S, Marfa MP, Vanier MT, Walterfang M, Bolton S, Dawson C, H&#x000e9;ron B, Stampfer M, Imrie J, Hendriksz C, Gissen P, Crushell E, Coll MJ, Nadjar Y, Kl&#x000fc;nemann H, Mengel E, Hrebicek M, Jones SA, Ory D, Bembi B, Patterson M, et al.  Consensus clinical management guidelines for Niemann-Pick disease type C. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2018;<span class="ref-vol">13</span>:50.</span> [<a href="/pmc/articles/PMC5889539/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5889539</span></a>] [<a href="/pubmed/29625568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29625568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.grau.1997.552">Grau AJ, Brandt T, Weisbrod M, Niethammer R, Forsting M, Cantz M, Vanier MT, Harzer K. Adult Niemann-Pick disease type C mimicking features of multiple sclerosis. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>1997;<span class="ref-vol">63</span>:552.</span> [<a href="/pmc/articles/PMC2169752/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2169752</span></a>] [<a href="/pubmed/9343150" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9343150</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.greer.1999.1252">Greer WL, Dobson MJ, Girouard GS, Byers DM, Riddell DC, Neumann PE. Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:1252–60.</span> [<a href="/pmc/articles/PMC1288277/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288277</span></a>] [<a href="/pubmed/10521290" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10521290</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.greer.1998.52">Greer WL, Riddell DC, Gillan TL, Girouard GS, Sparrow SM, Byers DM, Dobson MJ, Neumann PE. The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097--&#x0003e;T transversion in NPC1. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:52–4.</span> [<a href="/pmc/articles/PMC1377252/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377252</span></a>] [<a href="/pubmed/9634529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9634529</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.h_ron.2012.36">H&#x000e9;ron B, Valayannopoulos V, Baruteau J, Chabrol B, Ogier H, Latour P, Dobbelaere D, Eyer D, Labarthe F, Maurey H, Cuisset JM, de Villemeur TB, Sedel F, Vanier MT. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012;<span class="ref-vol">7</span>:36.</span> [<a href="/pmc/articles/PMC3465012/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3465012</span></a>] [<a href="/pubmed/22676771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22676771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.imrie.2002.491">Imrie J, Vijayaraghaven S, Whitehouse C, Harris S, Heptinstall L, Church H, Cooper A, Besley GT, Wraith JE. Niemann-Pick disease type C in adults. <span><span class="ref-journal">J Inherit Metab Dis. </span>2002;<span class="ref-vol">25</span>:491–500.</span> [<a href="/pubmed/12555942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12555942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.jiang.2011.1435">Jiang X, Sidhu R, Porter FD, Yanjanin NM, Speak AO, te Vruchte DT, Platt FM, Fujiwara H, Scherrer DE, Zhang J, Dietzen DJ, Schaffer JE, Ory DS. A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. <span><span class="ref-journal">J Lipid Res. </span>2011;<span class="ref-vol">52</span>:1435–45.</span> [<a href="/pmc/articles/PMC3122908/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3122908</span></a>] [<a href="/pubmed/21518695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21518695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.josephs.2004.2189">Josephs KA, Matsumoto JY, Lindor NM. Heterozygous Niemann-Pick disease type C presenting with tremor. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">63</span>:2189–90.</span> [<a href="/pubmed/15596783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15596783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.josephs.2003.528">Josephs KA, Van Gerpen MW, Van Gerpen JA. Adult onset Niemann-Pick disease type C presenting with psychosis. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2003;<span class="ref-vol">74</span>:528–9.</span> [<a href="/pmc/articles/PMC1738356/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1738356</span></a>] [<a href="/pubmed/12640083" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12640083</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.kanbayashi.2003.52">Kanbayashi T, Abe M, Fujimoto S, Miyachi T, Takahashi T, Yano T, Sawaishi Y, Arii J, Szilagyi G, Shimizu T. Hypocretin deficiency in niemann-pick type C with cataplexy. <span><span class="ref-journal">Neuropediatrics. </span>2003;<span class="ref-vol">34</span>:52–3.</span> [<a href="/pubmed/12690569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12690569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.kl_nemann.2002.743">Kl&#x000fc;nemann HH, Elleder M, Kaminski WE, Snow K, Peyser JM, O'Brien JF, Munoz D, Schmitz G, Klein HE, Pendlebury WW. Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2. <span><span class="ref-journal">Ann Neurol. </span>2002;<span class="ref-vol">52</span>:743–9.</span> [<a href="/pubmed/12447927" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12447927</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.liscum.2004.22">Liscum L, Sturley SL. Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport. <span><span class="ref-journal">Biochim Biophys Acta. </span>2004;<span class="ref-vol">1685</span>:22–7.</span> [<a href="/pubmed/15465423" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15465423</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.lloydevans.2008.1247">Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, Sillence DJ, Churchill GC, Schuchman EH, Galione A, Platt FM. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. <span><span class="ref-journal">Nat Med. </span>2008;<span class="ref-vol">14</span>:1247–55.</span> [<a href="/pubmed/18953351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18953351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.lloydevans.2011.200">Lloyd-Evans E, Platt FM. Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. <span><span class="ref-journal">Cell Calcium. </span>2011;<span class="ref-vol">50</span>:200–5.</span> [<a href="/pubmed/21724254" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21724254</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.mellon.2002.35">Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. <span><span class="ref-journal">Trends Endocrinol Metab. </span>2002;<span class="ref-vol">13</span>:35–43.</span> [<a href="/pubmed/11750861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11750861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.millard.2005.28581">Millard EE, Gale SE, Dudley N, Zhang J, Schaffer JE, Ory DS. The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:28581–90.</span> [<a href="/pubmed/15908696" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15908696</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.millat.2005.220">Millat G, Bailo N, Molinero S, Rodriguez C, Chikh K, Vanier MT. Niemann-Pick C disease: use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">86</span>:220–32.</span> [<a href="/pubmed/16126423" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16126423</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.millat.2001a.1013">Millat G, Chikh K, Naureckiene S, Sleat DE, Fensom AH, Higaki K, Elleder M, Lobel P, Vanier MT. Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. <span><span class="ref-journal">Am J Hum Genet. </span>2001a;<span class="ref-vol">69</span>:1013–21.</span> [<a href="/pmc/articles/PMC1274348/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1274348</span></a>] [<a href="/pubmed/11567215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11567215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.millat.1999.1321">Millat G, Marcais C, Rafi MA, Yamamoto T, Morris JA, Pentchev PG, Ohno K, Wenger DA, Vanier MT. Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of western European descent and correlates with a classic juvenile phenotype. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:1321–9.</span> [<a href="/pmc/articles/PMC1288284/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288284</span></a>] [<a href="/pubmed/10521297" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10521297</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.millat.2001b.1373">Millat G, Marcais C, Tomasetto C, Chikh K, Fensom AH, Harzer K, Wenger DA, Ohno K, Vanier MT. Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. <span><span class="ref-journal">Am J Hum Genet. </span>2001b;<span class="ref-vol">68</span>:1373–85.</span> [<a href="/pmc/articles/PMC1226124/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226124</span></a>] [<a href="/pubmed/11333381" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11333381</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.morris.1999.493">Morris JA, Zhang D, Coleman KG, Nagle J, Pentchev PG, Carstea ED. The genomic organization and polymorphism analysis of the human Niemann-Pick C1 gene. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1999;<span class="ref-vol">261</span>:493–8.</span> [<a href="/pubmed/10425213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10425213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.mukherjee.2004.28">Mukherjee S, Maxfield FR. Lipid and cholesterol trafficking in NPC. <span><span class="ref-journal">Biochim Biophys Acta. </span>2004;<span class="ref-vol">1685</span>:28–37.</span> [<a href="/pubmed/15465424" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15465424</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.naureckiene.2000.2298">Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. Identification of HE1 as the second gene of Niemann-Pick C disease. <span><span class="ref-journal">Science. </span>2000;<span class="ref-vol">290</span>:2298–301.</span> [<a href="/pubmed/11125141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11125141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.neufeld.1999.9627">Neufeld EB, Wastney M, Patel S, Suresh S, Cooney AM, Dwyer NK, Roff CF, Ohno K, Morris JA, Carstea ED, Incardona JP, Strauss JF 3rd, Vanier MT, Patterson MC, Brady RO, Pentchev PG, Blanchette-Mackie EJ. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:9627–35.</span> [<a href="/pubmed/10092649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10092649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.palmeri.2005.171">Palmeri S, Tarugi P, Sicurelli F, Buccoliero R, Malandrini A, De Santi MM, Marciano G, Battisti C, Dotti MT, Calandra S, Federico A. Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage. <span><span class="ref-journal">Neurol Sci. </span>2005;<span class="ref-vol">26</span>:171–3.</span> [<a href="/pubmed/16086131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16086131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.park.2003.313">Park WD, O'Brien JF, Lundquist PA, Kraft DL, Vockley CW, Karnes PS, Patterson MC, Snow K. Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1. <span><span class="ref-journal">Hum Mutat. </span>2003;<span class="ref-vol">22</span>:313–25.</span> [<a href="/pubmed/12955717" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12955717</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.passeggio.2005.10333">Passeggio J, Liscum L. Flux of fatty acids through NPC1 lysosomes. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:10333–9.</span> [<a href="/pubmed/15632139" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15632139</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.patterson.1993.61">Patterson MC, Di Bisceglie AM, Higgins JJ, Abel RB, Schiffmann R, Parker CC, Argoff CE, Grewal RP, Yu K, Pentchev PG. The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. <span><span class="ref-journal">Neurology. </span>1993;<span class="ref-vol">43</span>:61–4.</span> [<a href="/pubmed/8423912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8423912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.patterson.2012.330">Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F., NP-C Guidelines Working Group.  Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">106</span>:330–44.</span> [<a href="/pubmed/22572546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22572546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.patterson.2004.77">Patterson MC, Platt F. Therapy of Niemann-Pick disease, type C. <span><span class="ref-journal">Biochim Biophys Acta. </span>2004;<span class="ref-vol">1685</span>:77–82.</span> [<a href="/pubmed/15465428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15465428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.patterson.2007.765">Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. <span><span class="ref-journal">Lancet Neurol. </span>2007;<span class="ref-vol">6</span>:765–72.</span> [<a href="/pubmed/17689147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17689147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.patterson.2010.300">Patterson MC, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, Giorgino R, Wraith JE. Long-term miglustat therapy in children with Niemann-Pick disease type C. <span><span class="ref-journal">J Child Neurol. </span>2010;<span class="ref-vol">25</span>:300–5.</span> [<a href="/pubmed/19822772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19822772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.peake.2012.9290">Peake KB, Vance JE. Normalization of cholesterol homeostasis by 2-hydroxypropyl-beta-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice. <span><span class="ref-journal">J Biol Chem. </span>2012;<span class="ref-vol">287</span>:9290–8.</span> [<a href="/pmc/articles/PMC3308731/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3308731</span></a>] [<a href="/pubmed/22277650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22277650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.pentchev.1985.8247">Pentchev PG, Comly ME, Kruth HS, Vanier MT, Wenger DA, Patel S, Brady RO. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>1985;<span class="ref-vol">82</span>:8247–51.</span> [<a href="/pmc/articles/PMC391480/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC391480</span></a>] [<a href="/pubmed/3865225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3865225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.pineda.2009.243">Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, Bembi B, Walterfang M, Korenke GC, Marquardt T, Luzy C, Giorgino R, Patterson MC. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">98</span>:243–9.</span> [<a href="/pubmed/19656703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19656703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.pineda.2010.358">Pineda M, Perez-Poyato MS, O'Callaghan M, Vilaseca MA, Pocovi M, Domingo R, Portal LR, P&#x000e9;rez AV, Temudo T, Gaspar A, Pe&#x000f1;as JJ, Rold&#x000e1;n S, Fumero LM, de la Barca OB, Silva MT, Mac&#x000ed;as-Vidal J, Coll MJ. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">99</span>:358–66.</span> [<a href="/pubmed/20056559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20056559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.pineda.2018.140">Pineda M, Walterfang M, Patterson MC. Miglustat in Niemann-Pick disease type C patients: a review. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2018;<span class="ref-vol">13</span>:140.</span> [<a href="/pmc/articles/PMC6094874/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6094874</span></a>] [<a href="/pubmed/30111334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30111334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.pipalia.2011.5620">Pipalia NH, Cosner CC, Huang A, Chatterjee A, Bourbon P, Farley N, Helquist P, Wiest O, Maxfield FR. Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011;<span class="ref-vol">108</span>:5620–5.</span> [<a href="/pmc/articles/PMC3078401/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3078401</span></a>] [<a href="/pubmed/21436030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21436030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.porter.2010.56ra81">Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, Gale SE, Olzeski D, Sidhu R, Dietzen DJ, Fu R, Wassif CA, Yanjanin NM, Marso SP, House J, Vite C, Schaffer JE, Ory DS. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. <span><span class="ref-journal">Sci Transl Med. </span>2010;<span class="ref-vol">2</span>:56ra81.</span> [<a href="/pmc/articles/PMC3170139/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3170139</span></a>] [<a href="/pubmed/21048217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21048217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.ramirez.2010.309">Ramirez CM, Liu B, Taylor AM, Repa JJ, Burns DK, Weinberg AG, Turley SD, Dietschy JM. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. <span><span class="ref-journal">Pediatr Res. </span>2010;<span class="ref-vol">68</span>:309–15.</span> [<a href="/pmc/articles/PMC3065173/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3065173</span></a>] [<a href="/pubmed/20581737" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20581737</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.rosenbaum.2010.5477">Rosenbaum AI, Zhang G, Warren JD, Maxfield FR. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2010;<span class="ref-vol">107</span>:5477–82.</span> [<a href="/pmc/articles/PMC2851804/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2851804</span></a>] [<a href="/pubmed/20212119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20212119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.scott.2004.8">Scott C, Ioannou YA. The NPC1 protein: structure implies function. <span><span class="ref-journal">Biochim Biophys Acta. </span>2004;<span class="ref-vol">1685</span>:8–13.</span> [<a href="/pubmed/15465421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15465421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.stein.2012.434">Stein VM, Crooks A, Ding W, Prociuk M, O'Donnell P, Bryan C, Sikora T, Dingemanse J, Vanier MT, Walkley SU, Vite CH. Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2012;<span class="ref-vol">71</span>:434–48.</span> [<a href="/pmc/articles/PMC3352323/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3352323</span></a>] [<a href="/pubmed/22487861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22487861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.strauss.2002.947">Strauss JF 3rd, Liu P, Christenson LK, Watari H. Sterols and intracellular vesicular trafficking: lessons from the study of NPC1. <span><span class="ref-journal">Steroids. </span>2002;<span class="ref-vol">67</span>:947–51.</span> [<a href="/pubmed/12398991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12398991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.sullivan.2005.1021">Sullivan D, Walterfang M, Velakoulis D. Bipolar disorder and Niemann-Pick disease type C. <span><span class="ref-journal">Am J Psychiatry. </span>2005;<span class="ref-vol">162</span>:1021–2.</span> [<a href="/pubmed/15863815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15863815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.sun.2001.1361">Sun X, Marks DL, Park WD, Wheatley CL, Puri V, O, Brien JF, Kraft DL, Lundquist PA, Patterson MC, Pagano RE, Snow K. Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:1361.</span> [<a href="/pmc/articles/PMC1226123/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226123</span></a>] [<a href="/pubmed/11349231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11349231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.tang.2010.132">Tang Y, Li H, Liu JP. Niemann-Pick Disease Type C: from molecule to clinic. <span><span class="ref-journal">Clin Exp Pharmacol Physiol. </span>2010;<span class="ref-vol">37</span>:132–40.</span> [<a href="/pubmed/19566836" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19566836</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.tedeschi.1998.72">Tedeschi G, Bonavita S, Barton NW, Betolino A, Frank JA, Patronas NJ, Alger JR, Schiffmann R. Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>1998;<span class="ref-vol">65</span>:72–9.</span> [<a href="/pmc/articles/PMC2170174/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2170174</span></a>] [<a href="/pubmed/9667565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9667565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.vance.2011.204">Vance JE, Peake KB. Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin. <span><span class="ref-journal">Curr Opin Lipidol. </span>2011;<span class="ref-vol">22</span>:204–9.</span> [<a href="/pubmed/21412152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21412152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.vanier.1997.68">Vanier MT. Phenotypic and genetic heterogeneity in Niemann-Pick disease type C: current knowledge and practical implications. <span><span class="ref-journal">Wien Klin Wochenschr. </span>1997;<span class="ref-vol">109</span>:68–73.</span> [<a href="/pubmed/9060145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9060145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.vanier.2002.630">Vanier MT. Prenatal diagnosis of Niemann-Pick diseases types A, B and C. <span><span class="ref-journal">Prenat Diagn. </span>2002;<span class="ref-vol">22</span>:630–2.</span> [<a href="/pubmed/12124701" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12124701</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.vanier.2004.14">Vanier MT, Millat G. Structure and function of the NPC2 protein. <span><span class="ref-journal">Biochim Biophys Acta. </span>2004;<span class="ref-vol">1685</span>:14–21.</span> [<a href="/pubmed/15465422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15465422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.vanier.2010.16">Vanier MT. Niemann-Pick disease type C. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2010;<span class="ref-vol">5</span>:16.</span> [<a href="/pmc/articles/PMC2902432/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2902432</span></a>] [<a href="/pubmed/20525256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20525256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.vankova.2003.427">Vankova J, Stepanova I, Jech R, Elleder M, Ling L, Mignot E, Nishino S, Nevsimalova S. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C. <span><span class="ref-journal">Sleep. </span>2003;<span class="ref-vol">26</span>:427–30.</span> [<a href="/pubmed/12841368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12841368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.walkley.2004.48">Walkley SU, Suzuki K. Consequences of NPC1 and NPC2 loss of function in mammalian neurons. <span><span class="ref-journal">Biochim Biophys Acta. </span>2004;<span class="ref-vol">1685</span>:48–62.</span> [<a href="/pubmed/15465426" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15465426</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.walter.2003.243">Walter M, Davies JP, Ioannou YA. Telomerase immortalization upregulates Rab9 expression and restores LDL cholesterol egress from Niemann-Pick C1 late endosomes. <span><span class="ref-journal">J Lipid Res. </span>2003;<span class="ref-vol">44</span>:243–53.</span> [<a href="/pubmed/12576506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12576506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.walterfang.2011.1340">Walterfang M, Fahey M, Abel L, Fietz M, Wood A, Bowman E, Reutens D, Velakoulis D. Size and shape of the corpus callosum in adult Niemann-Pick type C reflects state and trait illness variables. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2011;<span class="ref-vol">32</span>:1340–6.</span> [<a href="/pubmed/21596811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21596811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.walterfang.2010.49">Walterfang M, Fahey M, Desmond P, Wood A, Seal ML, Steward C, Adamson C, Kokkinos C, Fietz M, Velakoulis D. White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">75</span>:49–56.</span> [<a href="/pubmed/20484681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20484681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.walterfang.2012a.462">Walterfang M, Macfarlane MD, Looi JC, Abel L, Bowman E, Fahey MC, Desmond P, Velakoulis D. Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. <span><span class="ref-journal">Eur J Neurol. </span>2012a;<span class="ref-vol">19</span>:462–7.</span> [<a href="/pubmed/22329857" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22329857</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.walterfang.2012b.76">Walterfang M, Yu-Chien C, Imrie J, Rushton D, Schubiger D, Patterson MC. Dysphagia as a risk factor for mortality in Niemann-Pick disease type C:systematic literature review and evidence from studies with miglustat. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012b;<span class="ref-vol">7</span>:76.</span> [<a href="/pmc/articles/PMC3552828/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3552828</span></a>] [<a href="/pubmed/23039766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23039766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.ward.2010.52">Ward S, O'Donnell P, Fernandez S, Vite CH. 2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease. <span><span class="ref-journal">Pediatr Res. </span>2010;<span class="ref-vol">68</span>:52–6.</span> [<a href="/pmc/articles/PMC2913583/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2913583</span></a>] [<a href="/pubmed/20357695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20357695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.watari.1999.805">Watari H, Blanchette-Mackie EJ, Dwyer NK, Glick JM, Patel S, Neufeld EB, Brady RO, Pentchev PG, Strauss JF 3rd. Niemann-Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>1999;<span class="ref-vol">96</span>:805–10.</span> [<a href="/pmc/articles/PMC15306/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC15306</span></a>] [<a href="/pubmed/9927649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9927649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.wiegand.2003.782">Wiegand V, Chang TY, Strauss JF 3rd, Fahrenholz F, Gimpl G. Transport of plasma membrane-derived cholesterol and the function of Niemann-Pick C1 Protein. <span><span class="ref-journal">FASEB J. </span>2003;<span class="ref-vol">17</span>:782–4.</span> [<a href="/pubmed/12594172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12594172</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.wijburg.2012.1560">Wijburg FA, Sedel F, Pineda M, Hendriksz CJ, Fahey M, Walterfang M, Patterson MC, Wraith JE, Kolb SA. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:1560–7.</span> [<a href="/pubmed/22517094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22517094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.wojtanik.2003.14850">Wojtanik KM, Liscum L. The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:14850–6.</span> [<a href="/pubmed/12591922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12591922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.wraith.2009.877">Wraith JE, Imrie J. New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat. <span><span class="ref-journal">Ther Clin Risk Manag. </span>2009;<span class="ref-vol">5</span>:877–87.</span> [<a href="/pmc/articles/PMC2781062/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2781062</span></a>] [<a href="/pubmed/19956552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19956552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.wraith.2010.351">Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, Giorgino R, Patterson MC. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">99</span>:351–7.</span> [<a href="/pubmed/20045366" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20045366</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.yamamoto.1999.10">Yamamoto T, Nanba E, Ninomiya H, Higaki K, Taniguchi M, Zhang H, Akaboshi S, Watanabe Y, Takeshima T, Inui K, Okada S, Tanaka A, Sakuragawa N, Millat G, Vanier MT, Morris JA, Pentchev PG, Ohno K. NPC1 gene mutations in Japanese patients with Niemann-Pick disease type C. <span><span class="ref-journal">Hum Genet. </span>1999;<span class="ref-vol">105</span>:10–6.</span> [<a href="/pubmed/10480349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10480349</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.yerushalmi.2002.44">Yerushalmi B, Sokol RJ, Narkewicz MR, Smith D, Ashmead JW, Wenger DA. Niemann-pick disease type C in neonatal cholestasis at a North American Center. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2002;<span class="ref-vol">35</span>:44–50.</span> [<a href="/pubmed/12142809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12142809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.zafeiriou.2003.242">Zafeiriou DI, Triantafyllou P, Gombakis NP, Vargiami E, Tsantali C, Michelakaki E. Niemann-Pick type C disease associated with peripheral neuropathy. <span><span class="ref-journal">Pediatr Neurol. </span>2003;<span class="ref-vol">29</span>:242–4.</span> [<a href="/pubmed/14629910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14629910</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="npc.REF.zervas.2001.1283">Zervas M, Somers KL, Thrall MA, Walkley SU. Critical role for glycosphingolipids in Niemann-Pick disease type C. <span><span class="ref-journal">Curr Biol. </span>2001;<span class="ref-vol">11</span>:1283–7.</span> [<a href="/pubmed/11525744" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11525744</span></a>]</div></li></ul></div></div><div id="npc.Chapter_Notes"><h2 id="_npc_Chapter_Notes_">Chapter Notes</h2><div id="npc.Author_Notes"><h3>Author Notes</h3><p>At the time of original submission of this profile, the author's work was supported by the National Niemann-Pick Disease Foundation; and he was principal investigator in a trial of OGT 918 in Niemann-Pick disease type C, sponsored by Cell Tech (UK) and subsequently sponsored by Actelion Pharmaceuticals, Inc. The author currently serves as Chair of the Scientific Advisory Committee of a registry of Niemann-Pick disease, type C, supported by Actelion Pharmaceuticals. He also serves as a consultant for Shire HGT, Orphazyme, and Genzyme.</p></div><div id="npc.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 August 2019 (aa) Revision: <a href="#npc.Testing">Testing</a>, <b>Biochemical</b> (assay of oxysterols); <a href="#npc.Therapies_Under_Investigation">Therapies Under Investigation</a> (miglustat)</div></li><li class="half_rhythm"><div>18 July 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 July 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 July 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> using biochemical testing no longer available clinically</div></li><li class="half_rhythm"><div>13 February 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 February 2004 (mp) Revision: testing</div></li><li class="half_rhythm"><div>18 December 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 September 2001 (mp) Revision</div></li><li class="half_rhythm"><div>26 January 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>20 October 1999 (mp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1296</span><span class="label">PMID: <a href="/pubmed/20301473" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301473</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/nbs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/nijmegen/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1296&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1296/?report=reader">PubReader</a></li><li><a href="/books/NBK1296/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1296" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1296" style="display:none" title="Cite this Page"><div class="bk_tt">Patterson M. Niemann-Pick Disease Type C. 2000 Jan 26 [Updated 2019 Aug 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1296/pdf/Bookshelf_NBK1296.pdf">PDF version of this page</a> (253K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#npc.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#npc.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#npc.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#npc.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#npc.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#npc.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#npc.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#npc.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#npc.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#npc.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#npc.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10577[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NPC2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4864[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NPC1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1296+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1462088" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1462088" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1462088" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1462088" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25238906" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[Niemann-Pick type C disease and psychosis: Two siblings].</a><span class="source">[Encephale. 2015]</span><div class="brieflinkpop offscreen_noflow">[Niemann-Pick type C disease and psychosis: Two siblings].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Maubert A, Hanon C, Metton JP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Encephale. 2015 Jun; 41(3):238-43. Epub 2014 Sep 18.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23928063" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Adult onset Niemann-Pick type C disease and psychosis: literature review].</a><span class="source">[Encephale. 2013]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Adult onset Niemann-Pick type C disease and psychosis: literature review].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Maubert A, Hanon C, Metton JP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Encephale. 2013 Oct; 39(5):315-9. Epub 2013 Aug 5.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20525256" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Niemann-Pick disease type C.</a><span class="source">[Orphanet J Rare Dis. 2010]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Niemann-Pick disease type C.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vanier MT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2010 Jun 3; 5:16. Epub 2010 Jun 3.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301601" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mole SE, Williams RE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11349231" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.</a><span class="source">[Am J Hum Genet. 2001]</span><div class="brieflinkpop offscreen_noflow">Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sun X, Marks DL, Park WD, Wheatley CL, Puri V, O'Brien JF, Kraft DL, Lundquist PA, Patterson MC, Pagano RE, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2001 Jun; 68(6):1361-72. Epub 2001 May 9.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301473" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301473" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc94b339a66ee2ba4b3a5d">Niemann-Pick Disease Type C - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Niemann-Pick Disease Type C - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:30:28-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE893577DFC8A281000000000556028C&amp;ncbi_session=CE893577DFC94B31_1366SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1296%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1296&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1296/&amp;ncbi_pagename=Niemann-Pick Disease Type C - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE893577DFC94B31_1366SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>